Supported by Evidence
“A US-funded hepatitis B vaccine trial in Guinea-Bissau that withholds treatment from some newborns is unethical according to WHO”
The World Health Organization publicly condemned a planned US-funded clinical trial in Guinea-Bissau that would withhold hepatitis B vaccine from some newborns in a placebo-controlled study. WHO stated that withholding an established, life-saving vaccine from newborns when it is already recommended as standard care violates ethical principles for clinical research.
global_health
3 sources
Updated Feb 15, 2026